Acinetobacter baumannii (A. baumannii) is recognized as a major pathogen causing nosocomial infections, particularly in patients admitted to intensive care units (ICU), and many widespread strains are resistant to almost all antibiotics currently in use. Carbapenemases belonging to molecular class D (OXA enzymes) have emerged globally as the main mechanism responsible for this resistance. This work aimed at detecting the spread of OXA carbapenemases in A. baumannii in ICU patients and to identify the susceptibility patterns of strains to polymyxin E (colistin), polymyxin B, and tigecycline as a promising option for treatment. Twenty seven clinical isolates of A. baumannii, collected from Alexandria Main University Hospital, were included in this study. A. baumannii was isolated from different clinical samples from ICU patients. All 27 isolates were subjected to complete identification and antimicrobial susceptibility testing. The identified carbapenem resistant A. baumannii strains were tested for the presence of bla and blaOXA-51 genes using multiplex PCR assay. Colistin and polymyxin B were found to be active upon the majority of identified resistant A. baumannii strains, where around 70% of the strains were sensitive to both of them, while tigecycline was found to be more effective as 92.5% of strains were sensitive to it. Resistance to carbapenems was mediated by both OXA-51 (100%) and OXA-23 (92.5%) for the tested A. baumannii strains.
INTRODUCTION
A.
baumannii persistence in hospital environments and propensity to cause outbreaks are contributed to its increasing resistance to antimicrobial drugs, including carbapenems, and resistance to desiccation and disinfectants. (3, 4) Several studies have shown the geographically widespread occurrence of multidrug-resistant A.
baumannii strains, which suggested a clonal relatedness of these strains. OXA-24-like; OXA-51-like; and OXA-58. (5) Recently it has been suggested that 
The bla Carbapenemases OXA-58 were first described in Europe, where they are widely disseminated. (11, 12) In South America, the presence of the gene was described in 
MATERIAL AND METHODS

A. baumannii isolates:
From For polymyxin E (colistin) and polymyxin B, the zone diameter were (resistant ≤12 mm, intermediate= 13, susceptible ≥14 mm).
Isolates were considered susceptible to tigecycline if they had an inhibition zone diameter of ≥13 mm. A. baumannii strains were considered to be carbapenem resistant when they were found to be resistant to all beta-lactams, including carbapenems (carbapenemase producing bacteria). 
1) DNA Extraction
DNA was extracted from the 27 carbapenem resistant A. baumanii isolates by boiling five colonies of fresh organism culture in 20 μl of sterile distilled water for 5minutes, followed by centrifugation for 2 min at 8000 rpm, them supernatants were used for amplification. All A. baumannii strains had the bla OXA-51 gene and with the exception of 2 strains they all also harbored bla . None of the tested strains was positive for bla or bla OXA-24 genes by PCR assay. (Table 5 Figure1) In the present study, the most common site of A. baumannii isolation was endotracheal aspirates 15 (55.5%), followed by pus from wounds 5 (18.5%), and sputum 3 (11.2%), Similar findings were also reported by Nasr and Attalah, (27) who isolated A.
2) Amplification Reaction
baumannii from 3 ICU in Cairo, whereas 14 (70%) of isolates were from VAP, followed by 91.3% of the tested isolates, respectively.
High sensitivity to colistin were also reported, one study found that 98% of carbapenemresistant A. baumannii were susceptible to colistin.
Noticeably, Frickmann et al (36) reported that colistin among 24 tested antibiotics was the only effective one against all MDR isolates. and an intrinsic chromosomal OXA-51. (6, 39) In the present study, all the carbapenemresistant A. baumannii strains were tested for OXA-23, OXA-24, OXA-58 and OXA-51 genes using PCR assay. All strains (100%)
were positive for bla OXA-51 gene, and all except 2 were positive for bla OXA-23 ( 
